| Literature DB >> 29746834 |
Alberto Peretti1, Eileen M Geoghegan1, Diana V Pastrana1, Sigrun Smola2, Pascal Feld2, Marlies Sauter2, Stefan Lohse2, Mayur Ramesh3, Efrem S Lim4, David Wang4, Cinzia Borgogna5, Peter C FitzGerald1, Valery Bliskovsky1, Gabriel J Starrett6, Emily K Law7, Reuben S Harris7, J Keith Killian1, Jack Zhu1, Marbin Pineda1, Paul S Meltzer1, Renzo Boldorini8, Marisa Gariglio5, Christopher B Buck9.
Abstract
BK polyomavirus (BKV) frequently causes nephropathy (BKVN) in kidney transplant recipients (KTRs). BKV has also been implicated in the etiology of bladder and kidney cancers. We characterized BKV variants from two KTRs who developed BKVN followed by renal carcinoma. Both patients showed a swarm of BKV sequence variants encoding non-silent mutations in surface loops of the viral major capsid protein. The temporal appearance and disappearance of these mutations highlights the intra-patient evolution of BKV. Some of the observed mutations conferred resistance to antibody-mediated neutralization. The mutations also modified the spectrum of receptor glycans engaged by BKV during host cell entry. Intriguingly, all observed mutations were consistent with DNA damage caused by antiviral APOBEC3 cytosine deaminases. Moreover, APOBEC3 expression was evident upon immunohistochemical analysis of renal biopsies from KTRs. These results provide a snapshot of in-host BKV evolution and suggest that APOBEC3 may drive BKV mutagenesis in vivo. Published by Elsevier Inc.Entities:
Keywords: APOBEC; APOBEC3; BKPyV; JCPyV; JCV; bladder; carcinoma; human polyomavirus; urothelial
Mesh:
Substances:
Year: 2018 PMID: 29746834 PMCID: PMC5953553 DOI: 10.1016/j.chom.2018.04.005
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023